-transparent.png){kind=logo}
Pleural thickening was observed in 4 patients during treatment with bromocriptine in dosages of 10-90 mg/day. Three patients who received at least 50 mg/day developed respiratory symptoms, elevated ESR and pleural effusion, which were normalized after withdrawal of the drug or reduction of the dosage. However, the pleural thickening was not fully reversible in any of the patients.
Related Publications
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
November 1988,
Chest,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
February 1981,
Lancet (London, England),
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
May 1988,
Ugeskrift for laeger,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
April 1986,
Thorax,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
February 1989,
Archives of internal medicine,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
January 1986,
Therapie,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
March 1984,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
October 1988,
Archives of internal medicine,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
December 1987,
Journal of neurology, neurosurgery, and psychiatry,
G Tornling, and
G Unge, and
G Axelsson, and
L Noring, and
A K Granerus
January 1985,
Annales de medecine interne,
